Navigation Links
Long-term marijuana smoking leads to respiratory complaints

Long-term exposure to marijuana smoke is linked to many of the same health problems as tobacco smoke, such as increased respiratory symptoms like cough, phlegm and wheeze, according to a new study by researchers at Yale School of Medicine.

Marijuana is the most widely used illicit drug in the United States, and abuse of the drug is on the rise. The study is published in today's Archives of Internal Medicine. First author Jeanette M. Tetrault, M.D., and colleagues sought to find the relationship between marijuana smoking and pulmonary function or respiratory complications.

"While there is convincing data on the effects of tobacco smoke on pulmonary clinical outcomes, the effect of marijuana smoke has been poorly understood," said Tetrault, ambulatory care fellow at Yale School of Medicine and the Department of Veterans Affairs Connecticut Healthcare System.

Tetrault and colleagues systematically reviewed articles from 1966 through 2005 identified from the MEDLINE, PsychINFO and EMBASE databases that evaluated the effect of marijuana smoking on pulmonary function and respiratory complications. Of the 34 articles that met selection criteria, 12 were classified as challenge studies because they examined the link between short-term marijuana use and airway response. Eleven of the 12 studies found an association between short-term marijuana use and relaxation and opening of the air passages.

The study's physiologic data failed to show an association between long-term marijuana smoking and airflow obstruction (emphysema). However, all 14 studies that assessed long-term marijuana smoking and respiratory complications noted an association with increased respiratory symptoms, suggesting obstructive lung disease.

The authors noted several common limitations among the studies, including inadequate control of the complicating effect of tobacco smoking; lack of standardized measures for the amount or duration of marijuana use; a nd lack of standardized measures of the outcomes that were evaluated.

"Despite these limitations, clinicians should advise their patients of the potential negative impact of marijuana smoking on overall lung health," said Tetrault.
'"/>

Source:Yale University


Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Long-term changes in experience cause neurons to sprout new long-lasting connections
3. Long-term cancer risk follows stem cell transplant recipients
4. Long-term narcotics use for back pain may be ineffective and lead to abuse
5. Canada approves marijuana-based pain spray
6. Scientists discover the bodys marijuana-like compounds are crucial for stress-induced pain relief
7. Good news for the medical marijuana movement: pot proliferates brain cells and boosts mood
8. Machinery of the marijuana munchies
9. New DNA fingerprinting technique separates hemp from marijuana
10. Enhancing activity of marijuana-like chemicals in brain helps treat
11. New study examines brains own marijuana

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology: